| Primary |
| Diffuse Large B-cell Lymphoma |
29.4% |
| Acute Myeloid Leukaemia |
10.9% |
| Plasma Cell Myeloma |
9.7% |
| Glioblastoma Multiforme |
8.7% |
| Medulloblastoma |
6.4% |
| Prophylaxis |
4.7% |
| Myelodysplastic Syndrome |
4.2% |
| Haematopoietic Neoplasm |
3.3% |
| Gastric Cancer |
3.0% |
| Brain Stem Glioma |
2.6% |
| Multiple Myeloma |
2.3% |
| Neuroblastoma |
2.1% |
| Non-small Cell Lung Cancer |
2.1% |
| Hypertension |
1.9% |
| Neoplasm |
1.7% |
| Constipation |
1.6% |
| Glioblastoma |
1.4% |
| Non-hodgkin's Lymphoma |
1.4% |
| Pancreatic Carcinoma |
1.3% |
| Chronic Myelomonocytic Leukaemia |
1.1% |
|
| White Blood Cell Count Decreased |
14.3% |
| Vomiting |
11.7% |
| Febrile Neutropenia |
11.0% |
| Sepsis |
6.5% |
| Thrombocytopenia |
6.5% |
| Neutrophil Count Decreased |
5.8% |
| Platelet Count Decreased |
4.5% |
| Pyrexia |
4.5% |
| Urinary Tract Infection |
4.5% |
| Embolism |
3.9% |
| Pneumonia |
3.9% |
| Respiratory Failure |
3.9% |
| Lung Infection |
3.2% |
| Syncope |
3.2% |
| Dyspnoea |
2.6% |
| Abdominal Pain |
1.9% |
| Death |
1.9% |
| Haemorrhage Intracranial |
1.9% |
| Herpes Zoster |
1.9% |
| Muscular Weakness |
1.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
31.4% |
| Multiple Myeloma |
12.1% |
| Diffuse Large B-cell Lymphoma |
10.4% |
| Product Used For Unknown Indication |
6.2% |
| Constipation |
5.8% |
| B-cell Lymphoma |
3.9% |
| Infection Prophylaxis |
3.4% |
| Hypertension |
3.1% |
| Insomnia |
3.0% |
| Glioblastoma Multiforme |
3.0% |
| Peripheral T-cell Lymphoma Unspecified |
2.9% |
| Acute Myeloid Leukaemia |
2.6% |
| Gastritis |
2.4% |
| Plasma Cell Myeloma |
1.7% |
| Breast Cancer |
1.6% |
| Supraventricular Extrasystoles |
1.5% |
| Medulloblastoma |
1.4% |
| Non-small Cell Lung Cancer |
1.3% |
| Pruritus |
1.2% |
| B-cell Lymphoma Recurrent |
1.2% |
|
| Myelodysplastic Syndrome Unclassifiable |
20.2% |
| Pneumonia |
10.3% |
| Vomiting |
7.8% |
| White Blood Cell Count Decreased |
7.3% |
| Thrombocytopenia |
6.8% |
| Pulmonary Embolism |
5.5% |
| Sepsis |
4.5% |
| Urinary Tract Infection |
4.5% |
| Cervical Dysplasia |
4.0% |
| Sternal Fracture |
4.0% |
| Febrile Neutropenia |
3.8% |
| Troponin I Increased |
3.0% |
| Soft Tissue Infection |
2.8% |
| Weight Decreased |
2.5% |
| Embolism |
2.3% |
| Pyrexia |
2.3% |
| Troponin Increased |
2.3% |
| Diarrhoea |
2.0% |
| Neutrophil Count Decreased |
2.0% |
| Renal Infarct |
2.0% |
|
| Concomitant |
| Multiple Myeloma |
22.7% |
| Product Used For Unknown Indication |
22.0% |
| Non-small Cell Lung Cancer |
15.6% |
| Breast Cancer |
7.8% |
| Drug Use For Unknown Indication |
7.8% |
| Plasma Cell Myeloma |
3.5% |
| Supplementation Therapy |
2.8% |
| Breast Cancer Metastatic |
2.1% |
| Osteomyelitis |
2.1% |
| Angiogram |
1.4% |
| Anti-infective Therapy |
1.4% |
| Anxiety |
1.4% |
| Glioblastoma Multiforme |
1.4% |
| Mantle Cell Lymphoma |
1.4% |
| Metastatic Renal Cell Carcinoma |
1.4% |
| Nuclear Magnetic Resonance Imaging |
1.4% |
| Sarcoma |
1.4% |
| Adenocarcinoma Pancreas |
0.7% |
| Allergic Cough |
0.7% |
| Anticoagulant Therapy |
0.7% |
|
| Hyponatraemia |
8.8% |
| Lymphocytic Leukaemia |
8.8% |
| Renal Failure |
8.8% |
| Urinary Tract Infection |
8.8% |
| Wound |
8.8% |
| Chest Pain |
5.9% |
| Pancytopenia |
5.9% |
| Small Intestinal Obstruction |
5.9% |
| Weight Decreased |
5.9% |
| Acute Febrile Neutrophilic Dermatosis |
2.9% |
| Bone Marrow Failure |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Crying |
2.9% |
| Culture Wound Positive |
2.9% |
| Death |
2.9% |
| Disease Progression |
2.9% |
| Drug Ineffective |
2.9% |
| Erectile Dysfunction |
2.9% |
| Fall |
2.9% |
| Gait Disturbance |
2.9% |
|
